Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia.
about
Cariprazine for Schizophrenia and Bipolar DisorderBrexpiprazole: A New Treatment Option for SchizophreniaExcess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors.Inequalities in healthcare provision for people with severe mental illness.Psychiatrists' approach to vascular risk assessment in Latin America.High aerobic intensity training and psychological States in patients with depression or schizophrenia.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.Soluble urokinase-type plasminogen activator receptor levels in patients with schizophreniaPrefrontal and Hippocampal Brain Volume Deficits: Role of Low Physical Activity on Brain Plasticity in First-Episode Schizophrenia Patients.Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven reviewMetabolic syndrome in patients with severe mental illness in GorganDevelopment of an integrated psychosocial treatment to address the medical burden associated with bipolar disorder.Quality of care for cardiovascular disease-related conditions in patients with and without mental disorders.The prevalence and risk factors of stroke in patients with chronic schizophrenia.Translation of the diabetes prevention program into a community mental health organization for individuals with severe mental illness: a case study.Sequential behavioral treatment of smoking and weight control in bipolar disorder.A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia.Association analysis of ANK3 gene variants with schizophrenia in a northern Chinese Han population.Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies.The association of Mediterranean diet and exercise modifications with anthropometric parameters in a psychiatric community population: A pilot study.Networks of blood proteins in the neuroimmunology of schizophrenia.Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-AnalysisSerious Mental Illness, Neighborhood Disadvantage, and Type 2 Diabetes Risk: A Systematic Review of the Literature
P2860
Q28071940-D100229E-21CD-478A-95C5-EDFF8074512FQ28079183-4EE9C4A6-BDF3-458A-95BB-2E89B240DFA7Q33663582-4A7F2E14-CC62-47A3-A0C9-04E37DAA1AC8Q34183475-9E73C9C7-406B-4550-8530-6AEFE7B9450CQ34224664-2D25BF3D-0A3D-41FE-887F-2AD66CF5BB5BQ34426258-2466C23F-8AE1-4CE7-A68D-28FA7B643722Q34623350-C569D892-B949-43C3-B231-104E5AA2BD49Q35016170-3D50146B-CBF6-4F30-88D8-5F6A88073015Q35048154-B13209A1-319B-4CD2-98DA-F1A8057A8A4FQ35369617-40F39235-CDE2-4F23-8C96-E2A2744A626FQ36303695-4A330571-45DF-46B3-8967-A7F9AA484302Q36600817-B7808874-E4F2-4948-B426-51E6D7136B4EQ36657453-F8F3099B-32BB-4BAB-B2FB-0EC7678A0087Q36860514-75B12C3C-178A-4B7F-8B77-7EA9A05E6DD4Q36870523-9E120C36-81D3-4882-AF24-6F43D51A9129Q36908408-ADCAF9D0-2DFF-422F-9337-6BD4EE6AA81CQ37030481-D701B7ED-1A11-4164-8DAC-01F6FC057223Q37031181-B41D0D4E-783D-43FD-8AE4-428E3D9E181AQ37127723-186352C1-0A32-4871-BAA5-01FB4A60DD78Q37699147-B13D10BA-9F0A-4835-80D9-770AA0C84C79Q38686408-76076A1C-E202-457A-8D63-E050623E14D2Q47554329-6A6E62E3-6E04-4F50-83B6-6DA417D92AF5Q54944546-5A6341E3-E3F8-4960-8736-8F09B4BF0275Q57073141-C7EA1B0F-131D-4E3B-A1A2-5E04E93EE6BBQ58695303-E3956DEC-159D-450D-81BF-E9A5407A696C
P2860
Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Increasing global burden of ca ...... d patients with schizophrenia.
@en
type
label
Increasing global burden of ca ...... d patients with schizophrenia.
@en
prefLabel
Increasing global burden of ca ...... d patients with schizophrenia.
@en
P1476
Increasing global burden of ca ...... nd patients with schizophrenia
@en
P2093
Charles H Hennekens
P478
68 Suppl 4
P577
2007-01-01T00:00:00Z